The use of record linkage for auditing the uptake and outcome of prenatal serum screening and prenatal diagnostic tests for Down syndrome

Prenatal Diagnosis

Volumn 23, Issue 10, 2003, Pages 801-806

  Alberman, Eva ^a   Huttly, Wayne ^a   Hennessy, Enid ^a   McIntosh, Alan ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Audit of prenatal screening and prenatal diagnosis; Maternity information systems; Prenatal Down syndrome screening; Record linkage

Indexed keywords

ARTICLE; COHORT ANALYSIS; DIAGNOSTIC TEST; DOWN SYNDROME; FETUS; FETUS ECHOGRAPHY; HUMAN; INFORMATION SYSTEM; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SERUM; MEDICAL AUDIT; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SCREENING TEST; ULTRASOUND;

ADULT; COHORT STUDIES; DOWN SYNDROME; FEMALE; HEMATOLOGIC TESTS; HUMANS; LONDON; MASS SCREENING; MEDICAL AUDIT; MEDICAL RECORD LINKAGE; PATIENT ACCEPTANCE OF HEALTH CARE; PHYSICIAN'S PRACTICE PATTERNS; PILOT PROJECTS; PREGNANCY; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY; UTILIZATION REVIEW;

EID: 0142073805     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.683     Document Type: Article

References (15)

1. Antenatal Subgroup of the UK National Screening Committee. Standards for Antenatal Screening including Specific Standards for Down syndrome Screening. http://www.doh.gov.uk/nsc/antenatal_screen/antenatal_screen_ind.htm.
2. Dormandy E, Michie S, Weinman J, Marteau T. 2002. Variation in the uptake of serum screening: the role of service delivery. Prenat Diagn 22: 67-69.
3. Ford C, Moore AJ, Jordan PA, et al. 1998. The value of screening for Down's syndrome in a socioeconomically deprived area with a high ethnic population. Br J Obstet Gynaecol 105: 855-859.
4. Hilder L, Alberman E. 1998. Monitoring fetal and infant survival using regional birth notification data in north east London. J Epidemiol Community Health 52: 253-258.
5. Huttly W, Dormandy E. Audit of Screening for Down's Syndrome in the North Thames Region. April 1995-March 1996. Wolfson Institute of Preventive Medicine. St Bartholomew's & The Royal London School of Medicine.
6. Huttly W, Dormandy E. Audit of Screening for Down's Syndrome in the North Thames Region. April 1996-March 1997. Wolfson Institute of Preventive Medicine. St Bartholomew's & The Royal London School of Medicine.
7. Morris JK, Mutton DE, Alberman E. 2000. Revised estimates of the maternal age specific live birth prevalence of Down's syndrome. J Med Screen 9: 2-6.
8. Mutton DE, Alberman E, Ide R, Bobrow M. 1991. Results of first year (1989) of a national register of Down's syndrome in England and Wales. Br Med J 303: 1295-1297.
9. North Thames Regional Health Authority. Maternal Serum Screening for Down's Syndrome and Open Neural Tube Defects. 1994-1995. Published 1996.
10. Wald NJ, Cuckle HS, Densem JW, et al. 1988. Maternal serum screening for Down's syndrome in early pregnancy. Br Med J 297: 883-888.
11. Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG. 1996. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat Diagn 16: 143-153.
12. Wald NJ, Densem JW, Smith D, Klee GG. 1994. Four marker serum screening for Down's syndrome. Prenat Diagn 14: 707-716.
13. Wald NJ, Huttly WJ, Hackshaw AK. 2003. Antenatal screening for Down's syndrome with the quadruple test. Lancet 361: 835-836.
14. Wald NJ, Kennard A, Densem JW, Cuckle HS, Chard T, Butler L. 1992. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. Br Med J 305: 391-394.
15. Wellesley D, Boyle T, Barber J, Howe DT. 2002. Retrospective audit of different antenatal screening policies for Down's syndrome in eight district general hospitals in one health region. Br Med J 325: 15-20.